deferoxamine has been researched along with pteridines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grisham, MB; Koyama, S; Robbins, RA; Sato, E; Simpson, KL | 1 |
| Arai, T; Endo, N; Fukuda, K; Hirota, K; Ishii, H; Makino, K; Mori, H; Sasada, M; Yamashita, K | 1 |
2 other study(ies) available for deferoxamine and pteridines
| Article | Year |
|---|---|
Effects of reactive oxygen and nitrogen metabolites on RANTES- and IL-5-induced eosinophil chemotactic activity in vitro.
Topics: Chemokine CCL5; Chemotaxis; Deferoxamine; Dithiothreitol; Dose-Response Relationship, Drug; Eosinophils; Humans; Hydrazines; Interleukin-5; Leukotriene B4; Molsidomine; Nitrates; Nitric Oxide; Nitrogen; Pteridines; Reactive Oxygen Species; Superoxides; Tyrosine; Xanthine | 1999 |
6-formylpterin, a xanthine oxidase inhibitor, intracellularly generates reactive oxygen species involved in apoptosis and cell proliferation.
Topics: Apoptosis; Catalase; Cell Division; Chelating Agents; Chromatography, High Pressure Liquid; Deferoxamine; Electrochemistry; Electron Spin Resonance Spectroscopy; Enzyme Inhibitors; fas Receptor; HL-60 Cells; Humans; Hydrogen Peroxide; Jurkat Cells; NAD; Nucleotides; Oxidation-Reduction; Oxygen Consumption; Pteridines; Pterins; Reactive Oxygen Species; Superoxides; Xanthine Oxidase | 2001 |